Category: DSM-5 EPPP Lecture Series

The video below is the section for Autism from Part 4 of TSM’s lecture series on DSM-5 and the EPPP, followed by a transcript. This lecture series aims to equip those preparing for the EPPP with everything you need to know about the impact DSM-5 will be having on the EPPP. To watch all of Part 4, click HERE. To watch earlier lectures in this series, or register for our webinar series on DSM-5 and the EPPP, click HERE.

Transcript of DSM-5 EPPP Lecture Video: Autism (Within the Abnormal Domain)

NARRATIVE DEFINITION: Autism Spectrum Disorder is a neurodevelopmental disorder characterized by difficulties communicating and interacting in a variety of social contexts, restricted and repetitive behaviors or interests, and early onset of symptoms that ultimately cause clinically significant impairment in everyday functioning. A reliable diagnosis of Autism Spectrum Disorder may be made as early as age 2, but symptoms may be recognized earlier than 12 months, depending upon the severity.

Continue reading →

The video below is the section for Specific Learning Disorders from Part 4 of TSM’s lecture series on DSM-5 and the EPPP, followed by a transcript. This lecture series aims to equip those preparing for the EPPP with everything you need to know about the impact DSM-5 will be having on the EPPP. To watch all of Part 4, click HERE. To watch earlier lectures in this series, or register for our webinar series on DSM-5 and the EPPP, click HERE.

Transcript of DSM-5 EPPP Lecture Video: Specific Learning Disorders

NARRATIVE DEFINITION: Specific learning disorder is a neurodevelopmental disorder with a biological origin that is the basis for cognitive abnormalities associated with behavioral signs of the disorder.  Genetic, epigenetic, and environmental factors can affect the brain’s ability to accurately and efficiently perceive or process verbal and non-verbal information.  An essential feature of specific learning disorders is the persistent difficulty to learn key academic skills, despite interventions that target those difficulties. Academic skills affected include reading, reading comprehension, written expression, spelling, arithmetic calculation and mathematical reasoning. The onset of difficulty in learning is during the years of formal schooling.  Diagnostic criteria are to be met based on a synthesis of multiple sources of information, including school reports, the individual’s history (developmental, medical, family, and educational), and psychoeducational assessment.
Continue reading →

The video below is the section for ADHD  from Part 4 of TSM’s lecture series on DSM-5 and the EPPP, followed by a transcript. This lecture series aims to equip those preparing for the EPPP with everything you need to know about the impact DSM-5 will be having on the EPPP. To watch all of Part 4, click HERE. To watch earlier lectures in this series, or register for our webinar series on DSM-5 and the EPPP, click HERE.

Transcript of DSM-5 EPPP Lecture Video: ADHD

NARRATIVE DEFINITION: Attention-Deficit/Hyperactivity Disorder (ADHD) is a substantially heritable and a lifelong condition which is first evident in childhood.  It is characterized by developmentally inappropriate and impairing symptoms of inattention and/or hyperactivity and impulsivity.

Continue reading →

Anyone taking the EPPP is now expected to know the material in DSM-5, the new edition of the Diagnostic and Statistical Manual of Mental Disorders. The changes that the American Psychiatric Association introduced in DSM-5 incorporate significant scientific advances in more precisely identifying and diagnosing mental disorders.

DSM-5 represents an opportunity to better integrate neuroscience and the wealth of findings from neuroimaging, genetics, and cognitive research that have emerged over the past several decades, all of which are vital to diagnosis and treatment.

It also provides a common language for clinicians to communicate about their patients and establishes consistent and reliable diagnoses that can be used in the research of mental disorders. In addition, it establishes a common language for researchers to study the criteria for potential future revisions and to aid in the development of medications and other interventions.

Many people who are studying to pass their EPPP are nervous about these changes, and have been asking some of the following questions: What is the relationship between DSM-5 and the EPPP, and how will the former affect the later? How will I learn what I need to know for the various EPPP content areas that have been affected by DSM-5? Is everything I learned before about mental illness suspect and unreliable? Are my test-preparation materials up to date with DSM-5?

Since your EPPP success is important to us at the Taylor Study Method, we have been running a lecture series on DSM-5 and the EPPP. The purpose of the Taylor Study Method’s DSM-5 Learning Series series aims to

1. to provide an overview of the content areas that the DSM-5 has integrated
2. to identify the critical points you’ll need to remember regarding the various content areas
3. to utilize motion graphic illustrations and footage to help you further consolidate and retain this new DSM-5 information
4. to demonstrate how the content areas may be presented to you as a question on your licensing exam

In order to fully address these concerns, Part 3 of our lecture series looks at five mental disorders affected by DSM-5. Alternatively, the following links will take you to a video and full transcript for each of these areas:

• Female Sexual Dysfunction: DSM-5 EPPP Lecture Video by Taylor Study Method
• Paraphilic Disorders: DSM-5 EPPP Lecture Video by Taylor Study Method
• Male Sexual Dysfunction: DSM-5 EPPP Lecture Video by Taylor Study Method
• Alcohol Withdrawal: DSM-5 EPPP Lecture Video by Taylor Study Method
• Substance and Medication-Induced Neurocognitive Disorder: DSM-5 EPPP Lecture Video by Taylor Study Method

We trust this series will be very beneficial to you as you take this final step towards licensure.

You can watch Part 1 and Part 2 in this lecture series, and register for future webinars, by clicking here.

The video below is the section for Substance and Medication-Induced Major or Mild Neurocognitive Disorder from Part 3 of TSM’s lecture series on DSM-5 and the EPPP, followed by a transcript. This lecture series aims to equip those preparing for the EPPP with everything you need to know about the impact DSM-5 will be having on the EPPP. To watch all of Part 3, click HERE. To watch Part 1 and 2, or register for our webinar series on DSM-5 and the EPPP, click HERE.

Transcript of DSM-5 EPPP Lecture Video: Substance and Medication-Induced Neurocognitive Disorder

NARRATIVE DEFINITION: Substance/Medication-Induced Major or Mild Neurocognitive Disorder

Substance/Medication-Induced Major or Mild Neurocognitive Disorder (previously Substance-Induced Persisting Dementia) can be specifically coded for alcohol if this substance is the cause of the neurocognitive symptoms.  In addition to listing the specific substance (e.g., alcohol), the DSM-5 specifies whether the symptoms are Persistent – the neurocognitive impairment continues even after the substance use has ceased.

Continue reading →

The video below is the section for Alcohol Withdrawal from Part 3 of TSM’s lecture series on DSM-5 and the EPPP, followed by a transcript. This lecture series aims to equip those preparing for the EPPP with everything you need to know about the impact DSM-5 will be having on the EPPP. To watch all of Part 3, click HERE. To watch Part 1 and 2, or register for our webinar series on DSM-5 and the EPPP, click HERE.

Transcript of DSM-5 EPPP Lecture Video: Alcohol Withdrawal

NARRATIVE DEFINITION: Alcohol Withdrawal is listed in the DSM-5 as one of five disorders under Alcohol-Related Disorders.  Alcohol Withdrawal often occurs in individuals who cease to drink or cutback markedly in drinking after a period of prolonged or heavy alcohol consumption. It usually occurs in individuals who have developed Alcohol Dependence.

Continue reading →

The video below is the section for Male Sexual Disfunctions from Part 3 of TSM’s lecture series on DSM-5 and the EPPP, followed by a transcript. This lecture series aims to equip those preparing for the EPPP with everything you need to know about the impact DSM-5 will be having on the EPPP. To watch all of Part 3, click HERE. To watch Part 1 and 2, or register for our webinar series on DSM-5 and the EPPP, click HERE.

Transcript of DSM-5 EPPP Lecture Video: Male Sexual Disfunctions

NARRATIVE DEFINITION: Delayed Ejaculation, Erectile Disorder, Male Hypoactive Sexual Desire Disorder, and Premature (Early) Ejaculation are sexual disorders specific to men. They are diagnosed when the symptoms cause significant distress or interpersonal disturbances and are not solely due to the effects of a drug or another medical condition.

Continue reading →

The video below is the section for Paraphilic Disorders from Part 3 of TSM’s lecture series on DSM-5 and the EPPP, followed by a transcript. This lecture series aims to equip those preparing for the EPPP with everything you need to know about the impact DSM-5 will be having on the EPPP. To watch all of Part 3, click HERE. To watch Part 1 and 2, or register for our webinar series on DSM-5 and the EPPP, click HERE.

Transcript of DSM-5 EPPP Lecture Video: Paraphilic Disorders

NARRATIVE DEFINITION: The DSM-5 explains that the term paraphilia refers to any “intense and persistent sexual interest other than sexual interest in genital stimulation or preparatory fondling with phenotypically normal, physically mature, consenting human partners. The presence of a paraphilia does not equal a diagnosis.  A paraphilic disorder is a paraphilia that is causing current distress or impairment to the individual, or a paraphilia that is satisfied at the risk of harm to another.  The Paraphilic Disorders listed in the DSM-5 are not an exhaustive list, but were included because they are more commonly seen than a number of other paraphilic disorders, including some which have the potential to be harmful to others and are classed as criminal offenses.

Continue reading →

The video below is the section for Female Sexual Dysfunction from Part 3 of TSM’s lecture series on DSM-5 and the EPPP, followed by a transcript. This lecture series aims to equip those preparing for the EPPP with everything you need to know about the impact DSM-5 will be having on the EPPP. To watch all of Part 3, click HERE. To watch Part 1 and 2, or register for our webinar series on DSM-5 and the EPPP, click HERE.

Transcript of DSM-5 EPPP Lecture Video: Female Sexual Dysfunction

NARRATIVE DEFINITION: Sexual Dysfunctions are disorders in desire, arousal and orgasm. Sexual disorders described in the DSM-5 that are found specifically in women include Female Orgasmic Disorder, Female Sexual Interest/Arousal Disorder, and Genito-Pelvic/Penetration Disorder.

Continue reading →

Anyone taking the EPPP is now expected to know the material in DSM-5, the new edition of the Diagnostic and Statistical Manual of Mental Disorders. The changes that the American Psychiatric Association introduced in DSM-5 incorporate significant scientific advances in more precisely identifying and diagnosing mental disorders.

DSM-5 represents an opportunity to better integrate neuroscience and the wealth of findings from neuroimaging, genetics, and cognitive research that have emerged over the past several decades, all of which are vital to diagnosis and treatment.

It also provides a common language for clinicians to communicate about their patients and establishes consistent and reliable diagnoses that can be used in the research of mental disorders. In addition, it establishes a common language for researchers to study the criteria for potential future revisions and to aid in the development of medications and other interventions.

Many people who are studying to pass their EPPP are nervous about these changes, and have been asking some of the following questions: What is the relationship between DSM-5 and the EPPP, and how will the former affect the later? How will I learn what I need to know for the various EPPP content areas that have been affected by DSM-5? Is everything I learned before about mental illness suspect and unreliable? Are my test-preparation materials up to date with DSM-5?

Since your EPPP success is important to us at the Taylor Study Method, we have been running a lecture series on DSM-5 and the EPPP. The purpose of the Taylor Study Method’s DSM-5 Learning Series series aims to

1. to provide an overview of the content areas that the DSM-5 has integrated
2. to identify the critical points you’ll need to remember regarding the various content areas
3. to utilize motion graphic illustrations and footage to help you further consolidate and retain this new DSM-5 information
4. to demonstrate how the content areas may be presented to you as a question on your licensing exam

In order to fully address these concerns, Part 2 of our lecture series looks at five mental disorders affected by DSM-5. You can watch the entire Part 1 lecture series in the video above. Alternatively, the following links will take you to a video and full transcript for each of these areas:

We trust this series will be very beneficial to you as you take this final step towards licensure.

 

Further Reading

• Neurocognitive Disorder Due to Alzheimer’s Disease: DSM-5 EPPP Lecture Video by Taylor Study Method
• Neurocognitive Disorder Due to Parkinson’s Disease: DSM-5 EPPP Lecture Video by Taylor Study Method
• Neurocognitive Disorder Due to HIV Infection: DSM-5 EPPP Lecture Video by Taylor Study Method
• Vascular Neurocognitive Disorder: DSM-5 EPPP Lecture Video by Taylor Study Method
• Autism: DSM-5 EPPP Lecture Video by Taylor Study Method